NXEN OTC
Nexien BioPharma, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -99.2%
3Y: -99.8%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$64K
+21.3% ▲
Capital Expenditures
$4
+0.0% ▲
5Y CAGR: -83.2%
Free Cash Flow
-$64K
+21.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$31K
+62.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$2M | -$626K | -$362K | -$239K |
| Depreciation & Amort. | $0 | $0 | $0 | $50K | $0 |
| Stock-Based Comp. | $52K | $349K | $379K | $203K | $0 |
| Change in Working Capital | $36K | $7K | $14K | $3K | $38K |
| Other Non-Cash Items | $2M | $1M | $158K | $24K | $137K |
| Operating Cash Flow | -$148K | -$91K | -$75K | -$82K | -$64K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $4 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | -$4 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $78K | $147K | $0 | $20K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $12K | $20K | $25K | $0 | $13K |
| Financing Cash Flow | $12K | $98K | $174K | $0 | $33K |
| Net Change in Cash | -$136K | $7K | $99K | -$82K | -$31K |
| Cash End of Period | $11K | $18K | $117K | $35K | $4K |
| Free Cash Flow | -$148K | -$91K | -$75K | -$82K | -$64K |